AKT1 and Parkinson disease: CBD stimulates neuronal survival in models of Parkinson’s disease via the protein kinase B/mammalian target of rapamycin (AKT/mTOR) pathway through a mechanism involving TRPV1 (Gugliandolo et al., 2020) and can also induce cancer cell death by inhibiting AKT/mTOR (Pisanti et al., 2017).